Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
milnacipran (savella) (1 trial)
lornoxicam (1 trial)
eletriptan (relpax) (1 trial)
zolmitriptan (zomig) (1 trial)
Epilepsy (Phase 4)
Headache (Phase 2)
Migraine Disorders (Phase 4)
Migraine with Aura (Phase 4)
Migraine without Aura (Phase 4)
Trials (3 total)
Trial APIs (4 total)